Physician profile
John B Mitchell
NPI 1770015471
$561.36
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.80 · 2023: $489 · 2024: $17.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $150.13 | 2022-2024 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $102.68 | 2022-2023 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $79.41 | 2023 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $55.67 | 2023 | Austedo Xr |
| Pfizer INC. | $36.52 | 2023 | |
| Sanofi Pasteur INC. | $32.65 | 2023 | |
| Si-Bone, INC. | $23.05 | 2023 | |
| Abbvie INC. | $18.36 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.39 | 2023 | Eliquis |
| Astellas Pharma US INC | $17.20 | 2023 | Veozah |
| Corium, LLC | $15.80 | 2023 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.